TIP811: OTC Markets (OTCM): A Picks and Shovels Play in Modern Capital Markets w/ Kyle Grieve & Shawn O'Malley
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “TIP811: OTC Markets (OTCM): A Picks and Shovels Play in Modern Capital Markets w/ Kyle Grieve & Shawn O'Malley” inside PodZeus.
This episode of We Study Billionaires dives deep into OTC Markets Group (OTCM), a lesser-known but critically important infrastructure provider in the U.S. financial system. Despite being overshadowed by major exchanges like the NYSE and NASDAQ, OTC Markets serves over 12,000 securities—more than both major exchanges combined—while operating with fewer than 130 employees. The company generates exceptional financial results, compounding free cash flow at 14% annually since 2014, with nearly 60% gross margins and 34% operating margins. It operates through three core segments: OTC Link (trading infrastructure), corporate services (listing fees for small and international firms), and market data licensing (selling real-time data to broker-dealers and platforms like Bloomberg). The hosts explore how OTCM functions as a 'picks and shovels' business in the capital markets, benefiting from a quasi-monopoly due to regulatory barriers that prevent major exchanges from listing non-SEC-registered companies. The company’s pricing power, operating leverage, and low capital intensity make it a rare example of a high-quality, capital-light business with durable competitive advantages. Despite regulatory risks and cyclical revenue volatility, the hosts conclude that OTCM is a stable, high-quality compounder with strong management alignment and a compelling long-term value proposition. The episode also evaluates OTCM’s intrinsic value, projecting a 2030 enterprise value of $1.3 billion and a per-share target of $113—implying a 16% IRR plus a 4% dividend yield. However, due to regulatory uncertainty and the business’s dependence on government rules, the hosts recommend a cautious approach: starting with a small 1-2% position as a 'tracker' to build conviction. They emphasize that while OTCM is a high-quality business with strong moats, its future is tied to regulatory stability, making it a potentially powerful but risky long-term holding. The discussion underscores the importance of understanding infrastructure businesses that underpin markets, even when they’re not glamorous.
OTCM operates a critical, quasi-monopoly infrastructure for U.S. over-the-counter markets, serving more than 12,000 securities—more than NYSE and NASDAQ combined—with just 130 employees.
The company compounds free cash flow at 14% annually, with 60% gross margins and 34% operating margins—higher than Alphabet’s—despite minimal debt and no significant reinvestment needs.
OTCM’s three segments—OTC Link (trading infrastructure), corporate services (listing fees), and market data licensing (data sales)—generate recurring, sticky revenue with strong pricing power.
The business is capital-light, with negligible PPE spending and low variable costs, enabling massive operating leverage during market euphoria.
Despite regulatory risks, OTCM’s competitive advantages—regulatory moats, network effects, switching costs, and data moats—make it a durable, high-quality compounder.
…and 3 more takeaways available in PodZeus
The Hidden Infrastructure Behind Every OTC Trade
“You're listening to TIP. Every time you buy a stock that doesn't trade on the New York Stock Exchange or NASDAQ, a foreign company, a small cap, a pink sheet name, there's a company in the background collecting a tool. You've probably never thought about them and they've never thought about making you think about them. That company is OTC Markets.”
Decoding OTCM's Three Core Business Segments
The hosts break down OTCM’s three revenue streams: OTC Link (trading infrastructure), corporate services (listing fees), and market data licensing. OTC Link acts as a toll bridge, collecting fees from broker-dealers for trade execution and quote dissemination. Corporate services offers tiered listing options (OTCQX, OTCQB, Pink Sheets) with fixed, non-cyclical fees. Market data licensing sells real-time data to institutions and redistributors like Bloomberg, creating a sticky, recurring revenue stream.
Pricing Power, Operating Leverage, and the 'Picks and Shovels' Advantage
“And to me, OTC Markets is very much a picks and shovels company for investing in the growth of equity markets in aggregate.”
Regulatory Moats, Network Effects, and Competitive Advantages
OTCM’s competitive moat is rooted in decades of regulatory acceptance with the SEC and FINRA, creating a high barrier to entry. The hosts discuss cornered resources (regulatory relationships), network effects (data quality attracts more users), and switching costs (broker-dealers must re-certify workflows). Even though NASDAQ has applied to extend trading hours, the hosts believe this poses little existential threat due to OTCM’s early-mover advantage and niche focus.
The Risks: Regulatory Black Swans and Customer Concentration
“If the SEC decided that NASDAQ could list non-SEC listed equities, this would certainly degrade both OTC Link and its corporate services segment.”
“When you have a monopoly, you can raise prices. It's as simple as that.”
“If the SEC decided that NASDAQ could list non-SEC listed equities, this would certainly degrade both OTC Link and its corporate services segment.”
“You're listening to TIP. Every time you buy a stock that doesn't trade on the New York Stock Exchange or NASDAQ, a foreign company, a small cap, a pink sheet name, there's a company in the background collecting a tool.”
Hosts
Guests
OTC Markets Group
organization
Cromwell Coulson
person
SEC
organization
NASDAQ
organization
New York Stock Exchange
organization
Bloomberg
organization
Refinitiv
organization
FINRA
organization
Edgar Online
organization
VeriSign
organization
TIP804: Kinsale Capital Stock Deep Dive w/ Clay Finck & Daniel Mahncke
We Study Billionaires - The Investor’s Podcast Network • 1h 14m • 4/3/2026
TIP805: Stock Market Maestros w/ Kyle Grieve
We Study Billionaires - The Investor’s Podcast Network • 1h 4m • 4/5/2026
TIP806: Wise PLC w/ Kyle Grieve and Daniel Mahncke
We Study Billionaires - The Investor’s Podcast Network • 1h 32m • 4/10/2026
RWH067: Prudent Investing In Perilous Times w/ Matthew McLennan
We Study Billionaires - The Investor’s Podcast Network • 1h 37m • 4/12/2026
TIP807: Portfolio Review: Analyzing Holdings and Watchlist Companies for 2026 w/ Daniel Mahncke, Shawn O'Malley, & Kyle Grieve
We Study Billionaires - The Investor’s Podcast Network • 1h 48m • 4/16/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “TIP811: OTC Markets (OTCM): A Picks and Shovels Play in Modern Capital Markets w/ Kyle Grieve & Shawn O'Malley” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
